LENSAR (NASDAQ:LNSR) Upgraded by Lake Street Capital to Buy Rating

Lake Street Capital upgraded shares of LENSAR (NASDAQ:LNSR) from a hold rating to a buy rating in a research report report published on Wednesday, Marketbeat Ratings reports. Lake Street Capital currently has $10.00 price target on the stock.

A number of other brokerages have also issued reports on LNSR. BTIG Research raised LENSAR from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Tuesday, March 17th. Weiss Ratings restated a “sell (d-)” rating on shares of LENSAR in a research report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $10.00.

LENSAR Price Performance

Shares of LNSR opened at $5.97 on Wednesday. The firm has a 50-day simple moving average of $10.57 and a two-hundred day simple moving average of $11.23. The stock has a market cap of $71.28 million, a PE ratio of -2.06 and a beta of 0.99. LENSAR has a 1-year low of $5.35 and a 1-year high of $14.31.

LENSAR (NASDAQ:LNSR) last issued its quarterly earnings data on Tuesday, March 31st. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.02). The firm had revenue of $16.03 million for the quarter, compared to analysts’ expectations of $20.30 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in LNSR. Brandes Investment Partners LP grew its holdings in shares of LENSAR by 10.1% in the fourth quarter. Brandes Investment Partners LP now owns 856,216 shares of the company’s stock valued at $9,958,000 after purchasing an additional 78,513 shares in the last quarter. Vanguard Group Inc. lifted its holdings in LENSAR by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 507,603 shares of the company’s stock worth $6,269,000 after buying an additional 1,446 shares in the last quarter. Groupe la Francaise boosted its position in LENSAR by 99.5% in the 2nd quarter. Groupe la Francaise now owns 251,400 shares of the company’s stock valued at $3,311,000 after buying an additional 125,400 shares during the period. Geode Capital Management LLC boosted its position in LENSAR by 103.9% in the 2nd quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock valued at $2,890,000 after buying an additional 111,802 shares during the period. Finally, Credit Industriel ET Commercial grew its stake in shares of LENSAR by 0.8% in the fourth quarter. Credit Industriel ET Commercial now owns 124,483 shares of the company’s stock worth $1,448,000 after acquiring an additional 1,000 shares in the last quarter. Hedge funds and other institutional investors own 40.15% of the company’s stock.

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.